California State Teachers Retirement System (CalSTRS)’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,251
Closed -$30.1K 3091
2024
Q1
$30.1K Buy
+9,251
New +$101K ﹤0.01% 2585
2023
Q2
Sell
-4,131
Closed -$40.8K 3118
2023
Q1
$40.8K Sell
4,131
-305
-7% -$3.39K ﹤0.01% 2882
2022
Q4
$42.3K Buy
4,436
+2,541
+134% +$34K ﹤0.01% 2938
2022
Q3
$33K Sell
1,895
-88
-4% -$1.03K ﹤0.01% 3023
2022
Q2
$15K Buy
+1,983
New +$26.3K ﹤0.01% 3107

Other funds holding ANTX

California State Teachers Retirement System (CalSTRS)'s ANTX Position: Q2 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of AN2 Therapeutics (ANTX) in Q2 2024, closing a stake of 9,251 shares — an estimated $30.1K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ANTX in Q2 2022 and held it in 5 quarters. The position peaked at $42.3K in Q4 2022. 45 funds tracked by Wall St. Rank hold ANTX as of Q2 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining AN2 Therapeutics position as of Q2 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 9,251 AN2 Therapeutics shares in Q2 2024, an estimated $30.1K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in AN2 Therapeutics in Q2 2022 and held it in 5 quarters.
  • California State Teachers Retirement System (CalSTRS)'s AN2 Therapeutics position peaked at $42.3K in Q4 2022.
  • 45 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2024, filed 14 Aug 2024.